Clonal exhaustion as a mechanism to protect against severe immunopathology and death from an overwhelming CD8 T cell response

Frontiers in Immunology

Volumn 4, Issue DEC, 2013, Pages

  Cornberg, Markus ^a   Kenney, Laurie L ^b   Chen, Alex T ^b   Waggoner, Stephen N ^b   Kim, Sung Kwon ^b   Dienes, Hans P ^c   Welsh, Raymond M ^b   Selin, Liisa K ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CD8; Clonal exhaustion; Immunopathology; LCMV; Liver; Lung; T cells

Indexed keywords

EID: 84892147911     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00475     Document Type: Article

References (32)

1. Doherty PC, Zinkernagel RM. T-cell-mediated immunopathology in viral infections. Transplant Rev (1974) 19:89-120.
2. Selin LK, Wlodarczyk MF, Kraft AR, Nie S, Kenney LL, Puzone R, et al. Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. Autoimmunity (2011) 44(4):328-47. doi:10.3109/08916934.2011.523277
3. Cole GA, Nathanson N, Prendergast RA. Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature (1972) 238:335-7. doi:10.1038/238335a0
4. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJD, Suresh M, Altman JD, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med (1998) 188:2205-13. doi:10.1084/jem.188.12.2205
5. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MBA. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med (1984) 160:521-40. doi:10.1084/jem.160.2.521
6. Wherry EJ, Blattman JN, Murali-Krishna K, van der MR, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol (2003) 77:4911-27. doi:10.1128/JVI.77.8.4911-4927.2003
7. Welsh RM, McNally JM. Immune deficiency, immune silencing, and clonal exhaustion of T cell responses during viral infections. Curr Opin Microbiol (1999) 2:382-7. doi:10.1016/S1369-5274(99)80067-8
8. Chen HD, Fraire AE, Joris I, Brehm MA, Welsh RM, Selin LK. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol (2001) 2:1067-76. doi:10.1038/ni727
9. Selin LK, Varga SM, Wong IC, Welsh RM. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med (1998) 188:1705-15. doi:10.1084/jem.188.9.1705
10. Cornberg M, Chen AT, Wilkinson LA, Brehm MA, Kim SK, Calcagno C, et al. Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity. J Clin Invest (2006) 116:1443-56. doi:10.1172/JCI27804
11. Chen HD, Fraire AE, Joris I, Welsh RM, Selin LK. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol (2003) 163:1341-55. doi:10.1016/S0002-9440(10)63493-1
12. Kraft AR, Wlodarczyk MF, Kenney LL, Selin LK. PC61 (Anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection. J Virol (2013) 87:12636-47. doi:10.1128/JVI.00936-13
13. Wlodarczyk MF, Kraft AR, Chen HD, Kenney LL, Selin LK. Anti-IFN-gamma and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza a-specific memory T cells. J Immunol (2013) 190:2736-46. doi:10.4049/jimmunol.1201936
14. Wherry EJ. T cell exhaustion. Nat Immunol (2011) 131:492-9. doi:10.1038/ni.2035
15. Mueller SN, Ahmed R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A (2009) 106:8623-8. doi:10.1073/pnas.0809818106
16. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol (2007) 8:239-45. doi:10.1038/ni1443
17. Ludewig B, Odermatt B, Ochsenbein AF, Zinkernagel RM, Hengartner H. Role of dendritic cells in the induction and maintenance of autoimmune diseases. Immunol Rev (1999) 169:45-54. doi:10.1111/j.1600-065X.1999.tb01305.x
18. Zinkernagel RM, Planz O, Ehl S, Battegay M, Odermatt B, Klenerman P, et al. General and specific immunosuppression caused by antiviral T-cell responses. Immunol Rev (1999) 168:305-15. doi:10.1111/j.1600-065X.1999.tb01300.x
19. Zhou S, Ou R, Huang L, Price GE, Moskophidis D. Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection. J Virol (2004) 78:3578-600. doi:10.1128/JVI.78.3578-3600.2004
20. Fuller MJ, Zajac AJ. Ablation of CD8 and CD4 T cell responses by high viral loads. J Immunol (2003) 170:477-86.
21. Fuller MJ, Khanolkar A, Tebo AE, Zajac AJ. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J Immunol (2004) 172:4204-14.
22. Yi JS, Cox MA, Zajac AJ. T-cell exhaustion: characteristics, causes and conversion. Immunology (2010) 129:474-81. doi:10.1111/j.1365-2567.2010.03255.x
23. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (1993) 362:758-61. doi:10.1038/362758a0
24. Kondo Y, Kobayashi K, Shiina M, Niitsuma H, Ueno Y, Kobayashi T, et al. Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8 T lymphocytes in fulminant hepatitis B. Liver Int (2004) 24:561-7. doi:10.1111/j.1478-3231.2004.0982.x
25. Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology (2008) 134(1938-49):1949. doi:10.1053/j.gastro.2008.03.037
26. Ou R, Zhang M, Huang L, Moskophidis D. Control of virus-specific CD8+ T-cell exhaustion and immune-mediated pathology by E3 ubiquitin ligase Cbl-b during chronic viral infection. J Virol (2008) 82:3353-68. doi:10.1128/JVI.01350-07
27. Johnson PL, Kochin BF, McAfee MS, Stromnes IM, Regoes RR, Ahmed R, et al. Vaccination alters the balance between protective immunity, exhaustion, escape, and death in chronic infections. J Virol (2011) 85:5565-70. doi:10.1128/JVI.00166-11
28. Ehl S, Klenerman P, Zinkernagel RM, Bocharov G. The impact of variation in the number of CD8(+) T-cell precursors on the outcome of virus infection. Cell Immunol (1998) 189:67-73. doi:10.1006/cimm.1998.1344
29. Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature (2012) 481:394-8. doi:10.1038/nature10624
30. Stamm A, Valentine L, Potts R, Premenko-Lanier M. An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells. Virology (2012) 425:122-32. doi:10.1016/j.virol.2012.01.005
31. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med (2005) 352:2598-608. doi:10.1056/NEJMoa043980
32. Chatenoud L. Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity. Curr Opin Organ Transplant (2009) 14:351-6. doi:10.1097/MOT.0b013e32832ce95a